Maryland Oncology Hematology Welcomes Colette Magnant, MD, FACS to Their Expanding Breast Surgical Oncology Team

Dr. Magnant joins Dr. Surupa Sen Gupta at their Rockville Division to offer the community advanced surgical care with the latest breast preservation techniques.

Maryland Oncology Hematology  (MOH), the largest independent oncology practice in Maryland and a member of The US Oncology Network, is proud to announce that Dr. Colette Magnant, MD, FACS is joining its Rockville division.

Dr. Magnant has been treating breast cancer for over 34 years and has established herself as one of the premier breast cancer surgeons in the Washington, D.C. metropolitan area.  With her extensive training and wealth of experience, she provides her patients with a superior understanding of breast cancer biology, as well as compassionate state of the art breast preservation procedures, and advanced surgical techniques. She will be joining Dr. Surupa Sen Gupta to expand our breast surgical oncology services at our Rockville division, and together they, along with our expert and experienced medical oncologists, will anchor our comprehensive breast cancer program in the Rockville division.

‘We’re thrilled to welcome Dr. Magnant  to our experienced breast surgical team. Her stellar reputation as a top breast surgeon is well-deserved and we are fortunate that she has decided to bring her skills to our practice and to our community.  She shares our vision of providing state-of-the-art multidisciplinary cancer care, and we are delighted to have her join in our expansion said George Sotos MD, Managing Partner, Rockville Division. ‘With her focus and strong surgical experience in breast cancer treatment, Dr. Magnant is a welcome addition to our team as we dedicate our practice to delivering the very best in comprehensive and integrated care to our breast cancer patients.

Dr. Magnant is board certified in general surgery, specializing in advanced breast surgery techniques, including skin and nipple-sparing mastectomies and minimally invasive breast conserving surgeries. After earning her medical degree from the Medical College of Virginia in Richmond, Dr. Magnant completed her general surgery internship at Indiana University Medical Center and her residency at Georgetown University Hospital in Washington, DC. She is most recently the past director of the Sullivan Center for Breast Health at Sibley Hospital, as well as an assistant professor at John Hopkins University. In addition to teaching, Dr. Magnant has made numerous media appearances and delivered dozens of university lectures.

‘I’m proud to work alongside the dynamic team at Maryland Oncology Hematology, said Dr. Magnant. ‘We’re dedicated to delivering compassionate and comprehensive breast health services to the surrounding community, allowing our patients to receive the best of care, close to home.

Dr. Magnant will be joining Dr. Sen Gupta who is board certified in general surgery, fellowship trained in breast surgical oncology, and specializes in minimally invasive breast-conserving surgeries.

Dr. Magnant will start seeing patients at MOH’s Rockville office on April 1st. Appointments are available for newly referred patients to provide a high level of support and easy access to care. Please call 301.424.6231 to make an appointment.

About Maryland Oncology Hematology

Maryland Oncology Hematology (MOH) is the largest independent oncology practice in the state of Maryland, with more than 45 practicing clinicians devoted exclusively to providing comprehensive, compassionate, and high-quality cancer care. MOH specializes in medical, gynecologic, hematology, cancer genetic risk assessment, clinical trials and research, and patient ancillary programs. MOH believes it is beneficial to provide cancer therapies in a community setting, close to patients’ homes and support systems. The physicians are supported by a talented clinical team sensitive to the needs of cancer patients and their caregivers. For more information, visit MarylandOncology.com.

About US Oncology Network

Maryland Oncology Hematology is a practice in The US Oncology Network  (The Network). This collaboration unites the practice with more than 1,380 independent physicians dedicated to delivering value-based, integrated care to patients — close to home. Through The Network, these independent doctors come together to form a community of shared expertise and resources dedicated to advancing local cancer care and to delivering better patient outcomes. The Network is supported by McKesson Corporation , whose coordinated resources and infrastructure allow doctors in The Network to focus on the health of their patients, while McKesson focuses on the health of their practices. MOH also participates in clinical trials through US Oncology Research, which has played a role in more than 100 FDA-approved cancer therapies.

 

Media Contact
Company Name: Maryland Oncology Hematology
Contact Person: Mark W Lamplugh Jr
Email: Send Email
Phone: 5617629729
Country: United States
Website: https://mdoncology.wpengine.com

 

Facebooktwitterlinkedinmail

Maryland Oncology Hematology and The US Oncology Network Welcome Cynthia Plate M.D. F.A.C.S, Specialist In Breast Surgery

Dr. Plate brings a new line of treatment services to the clinic, offering patients cutting-edge breast preservation techniques

 

Silver Spring, MD- November, 2020 Maryland Oncology Hematology, the premier provider of cancer services in the Maryland region, announced today it has added a breast surgical oncologist to the practice, enhancing the comprehensive multidisciplinary care it provides to breast patients. Cynthia Plate M.D. F.A.C.S specializes in breast surgery and has extensive training and experience in the field. MOH has been serving cancer patients in the Maryland area for over 40 years, providing patients convenient access to leading cancer experts and the most advanced cancer therapies available today.

Dr. Plate has many years of rigorous education, training, and experience focusing on breast disease and surgery, providing her with a superior understanding of breast cancer biology, genetics, and advanced oncoplastic surgical techniques and breast preservation procedures. By adding Dr. Plate to the practice, MOH’s new White Oak Cancer Center enhances its ability to offer multidisciplinary team care for all types of complex breast issues, including benign breast disease, malignancies, and management of high-risk patients. Seamless high-quality care is provided by a collaborative team of specialists in breast surgery, medical and radiation oncology, diagnostic imaging, pathology, genetic risk evaluation, and supportive care.

“Dr. Plate shares our passion of providing exceptional multidisciplinary cancer care, and we are delighted to have her join our growing practice” said Dr. Joseph Haggerty, President at Maryland Oncology Hematology. “With her focus on new surgical advancements in breast cancer treatment, Dr. Plate will be a great addition to our breast cancer team as we seek to deliver the best breast cancer treatment in the Maryland Region.”

Cynthia Plate M.D. F.A.C.S is board-certified in general surgery and is a breast care specialist. She previously worked with Adventist HealthCare Medical Group.

Dr. Plate graduated from Howard University College of Medicine and completed her internship and residency at Howard University Hospital

“Specializing in women’s breast health, I’m committed to providing my patients with exceptional and compassionate care,” said Dr. Plate. “I’m thrilled to join the MOH team where we can continue to deliver leading-edge cancer care to our community.”

Dr. Plate is currently seeing patients at MOH’s Silver Spring White Oak Cancer Center office. Timely appointments are available for newly referred patients, typically within 24 hours, to provide a high level of support and prompt access to care. Please call 301-933-3216 to make an appointment

 

About Maryland Oncology Hematology

 

Maryland Oncology Hematology is an affiliate of The US Oncology Network (The Network). This

collaboration unites MOH with more than 1,400 independent physicians dedicated to delivering value-based, integrated care for patients — close to home. Through The Network, these independent doctors come together to form a community of shared expertise and resources dedicated to advancing local cancer care and to delivering better patient outcomes. The US Oncology Network is supported by McKesson Specialty Health, whose coordinated resources and infrastructure allow doctors in The Network to focus on the health of their patients, while McKesson focuses on the health of their practices. MOH participates in clinical trials through US Oncology Research, which has played a role in more than 70 FDA-approved cancer therapies, approximately one-third of all cancer therapies approved by the FDA to date. For more information, visit www.usoncology.com.

 

About US Oncology Network

Maryland Oncology Hematology is a practice in The US Oncology Network (The Network). This collaboration unites the practice with more than 1,200 independent physicians dedicated to delivering value-based, integrated care to patients — close to home. Through The Network, these independent doctors come together to form a community of shared expertise and resources dedicated to advancing local cancer care and to delivering better patient outcomes. The Network is supported by McKesson Corporation, whose coordinated resources and infrastructure allow doctors in The Network to focus on the health of their patients, while McKesson focuses on the health of their practices. Maryland Oncology Hematology also participates in clinical trials through US Oncology Research, which has played a role in more than 100 FDA-approved cancer therapies.

 

 

Media Contacts:

 

Mark W Lamplugh Jr

The US Oncology Network

(561) 762-9729

mark.lamplugh@usoncology.com

Facebooktwitterlinkedinmail

Maryland Oncology Hematology to Open a New Cancer Center in Annapolis, MD

MOH’s new state-of-the-art facility will provide community cancer care to patients throughout the Annapolis area.

Beltsville, MD (10/28/20) – Maryland Oncology Hematology (MOH), a 48-physician privately-owned practice specializing in the diagnosis and treatment of cancer, announced it is opening its 13th location in Annapolis, MD. This new state-of-the-art facility will allow patients in Annapolis and the surrounding areas to access high-quality cancer care in a convenient community setting close to home. Maryland Oncology Hematology is now accepting appointments and will start seeing patients at the Annapolis office beginning November 2nd.

 

“With the opening of this new office, MOH will be providing the highest quality cancer care to the Annapolis community,” said Joseph Haggerty MD, Practice President, Maryland Oncology Hematology. “Patients will be able to receive leading-edge cancer care without having to travel long distances.”

 

Maryland Oncology Hematology in Annapolis will provide advanced care and comprehensive services including medical oncology, hematology, genetic risk assessment, and clinical research. Working as an independent practice allows MOH physicians the freedom to tailor care to each patient’s unique diagnosis. With one of the largest and most active clinical research programs conducted by a private practice in the state, MOH offers to its patients, among other things, the opportunity to participate in Phase I-IV clinical trials.

 

The multi-disciplinary team at the Annapolis location will deliver the latest in advanced, integrative cancer treatment. MOH is proud to announce that the following physicians will provide care at the new office:

 

Ravin J. Garg, MD

Peter R. Graze, MD

Stuart E. Selonick, MD

Jason D. Taksey, MD

Jeanine L. Werner, MD

 

 

MOH is further pleased to announce that Benjamin Bridges, MD, Adam J. Goldrich, MD, Carol K. Tweed, MD, and David E. Weng, MD will also be joining its team. These physicians will be temporarily practicing out of MOH’s office in Clinton, Maryland.

 

The MOH Annapolis office is located at 810 Bestgate Rd, Suite 400, Annapolis, MD, 21401. Physicians, patients, and family members can call 410.897.6200 to arrange a visit, consultation, or to make an appointment. The MOH Clinton office is located at 8926 Woodyard Rd #101 Clinton, MD 20735. Physicians, patients, and family members can call 301-812-3900 arrange a visit, consultation, or to make an appointment.

 

About Maryland Oncology Hematology

 

Maryland Oncology Hematology (MOH) is the largest independent oncology practice in the state of Maryland, with more than 48 practicing clinicians devoted exclusively to providing comprehensive, compassionate, and high-quality cancer care. MOH specializes in oncology & hematology services, cancer genetic risk assessment, clinical trials and research. MOH believes it is beneficial to provide cancer therapies in a community setting, close to patients’ homes and support systems. The physicians are supported by a talented clinical team sensitive to the needs of cancer patients and their caregivers. For more information, visit MarylandOncology.com.

 

 

 

Media Contacts

Mark Lamplugh

Maryland Oncology Hematology

561-762-9729

Mark.lamplugh@usoncology.com

Facebooktwitterlinkedinmail

PRESS RELEASE: Maryland Oncology Hematology is Now Offering Advanced Radiation Services

Maryland Oncology Hematology is Partnering with Adventist HealthCare to Offer Comprehensive Care that Includes Advanced Radiation Services at the White Oak Cancer Center

Dr. Luqman Dad will lead The Center of Advanced Radiation Oncology and provide state-of-the-art radiation services and technologies to patients in the region.

Maryland, October 20, 2020 – Maryland Oncology Hematology (MOH), the largest independent oncology practice in Maryland and a member of The US Oncology Network, has partnered with Adventist HealthCare to open The Center for Advanced Radiation Oncology at White Oak Cancer Center.

Led by radiation oncologist Luqman Dad, MD, the Center for Advanced Radiation Oncology at White Oak will work alongside the team at Maryland Oncology Hematology to offer compassionate, patient-centered, state-of-the-art radiation therapy. The center will offer seamless delivery of high-quality precise treatment by expert specialists, providing some of the latest in techniques and technologies, including: SBRT, IMRT, IGRT, SRS, and Brachytherapy, along with access to hyperbaric oxygen chamber for late toxicities and radiosensitization of recurrent tumors. The Center for Advanced Radiation Oncology will be located in the White Oak Cancer Center, where patients can have access to a comprehensive multidisciplinary approach to cancer including medical oncology/hematology, radiation oncology, surgical oncology, PET/CT imaging, genetics, research, nutrition, palliative care, social work, physical, occupational and speech rehabilitation.

Dr. Dad brings years of leadership and academic study to The Center of Advanced Radiation Oncology at White Oak Cancer Center. Born at the original Washington Adventist Hospital, Dr. Dad grew up just down the road from the White Oak Cancer Center and attended Paint Branch High School. He completed his undergraduate and medical studies at Boston University. In 2011, Dr. Dad returned to Maryland following the completion of his post-graduate training in Radiation Oncology at Roswell Park Cancer Institute. The Washington Metropolitan area remains close to his heart.

Medical Director, Radiation Oncology

 

“I’m proud to live in a community with great culture, diversity, and opportunities where we can make a tremendous impact and deliver top-notch cancer care,” said Dr. Dad, Medical Director at The Center for Advanced Radiation at White Oak. “At The Center for Advanced Radiation, we’re excited to provide personalized, innovative cancer treatments using the latest technologies.”

 

Dr. Luqman Dad serves as the Medical Director at The Center for Advanced Radiation Oncology at White Oak. He performs numerous procedures to treat patients at all stages of cancer care and is skilled in advanced radiation techniques, including stereotactic body radiation therapy (SBRT), intracranial radiosurgery (SRS), proton beam therapy, gynecologic high-dose rate (HDR) brachytherapy, and more. He is board certified in radiation oncology.

Through the affiliate partnership with the Maryland Proton Treatment Center (MPTC), Dr. Dad has access to this new advanced treatment that is only available in select cancer centers nationwide. Dr. Dad is able to see patients at the White Oak Cancer Center and collaborate with the team at MPTC if proton beam treatment is indicated for the patient.

Dr. Dad has a special interest in breast, prostate, lung, head and neck, gastrointestinal, lymphoma, and central nervous system malignancies. He has served as a lead physician in helping develop national clinical practice parameters for SBRT, as well as principal investigator on industry-sponsored clinical trials. Dr. Dad is an active member of the American Society for Radiation Oncology (ASTRO), where he serves on national committees and helps ASTRO in the global outreach of radiation oncology to underserved regions of the world.

“I’m looking forward to the opportunity to partner with Maryland Oncology Hematology to provide cutting-edge, evidencebased, patient-centered care to this community,” said Dr. Dad. “I believe that the dynamic location, supported by strong infrastructure and the future vision for the White Oak corridor as a hub for science and technology that will place The White Oak Radiation Oncology Program in a position for tremendous growth and success.”

Opening in November, The Center for Advanced Radiation Oncology at White Oak Cancer Center will be located at 11886 Healing Way Suite 101, Silver Spring, MD, 20904. To learn more or to schedule an appointment, visit MarylandOncology.com or call 301.343.3892.

 

About Maryland Oncology Hematology

 

Maryland Oncology Hematology (MOH) is the largest independent oncology practice in the state of Maryland, with more than 45 practicing clinicians devoted exclusively to providing comprehensive, compassionate, and high-quality cancer care. MOH specializes in medical, gynecologic, hematology, cancer genetic risk assessment, clinical trials and research, and patient ancillary programs. MOH believes it is beneficial to provide cancer therapies in a community setting, close to patients’ homes and support systems. The physicians are supported by a talented clinical team sensitive to the needs of cancer patients and their caregivers. For more information, visit MarylandOncology.com.

 

 

About US Oncology Network

Maryland Oncology Hematology is a practice in The US Oncology Network (The Network). This collaboration unites the practice with more than 1,200 independent physicians dedicated to delivering value-based, integrated care to patients — close to home. Through The Network, these independent doctors come together to form a community of shared expertise and resources dedicated to advancing local cancer care and to delivering better patient outcomes. The Network is supported by McKesson Corporation, whose coordinated resources and infrastructure allow doctors in The Network to focus on the health of their patients, while McKesson focuses on the health of their practices. Maryland Oncology Hematology also participates in clinical trials through US Oncology Research, which has played a role in more than 100 FDA-approved cancer therapies.

 

To be distributed to local media:

Practice: Maryland Oncology Hematology

Contact: Mark Lamplugh

Phone : 561-762-9729

Email : mark.lamplugh@usoncology.com

Facebooktwitterlinkedinmail

Quality Care Close to Home


View our locations on map!

Sign Up Today For Our E-Newsletter

United in Healing with The US Oncology Network - Maryland Oncology Hematology